![Danielle Keatley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Danielle Keatley worked as Head-Media Relations at Onyx Pharmaceuticals, Inc. from 2012 to 2013.
From 2016 to 2021, worked as Head-IR & Corporate Communications at Ultragenyx Pharmaceutical, Inc. Also worked as Head-Investor Relations at Structure Therapeutics, Inc.
Former positions of Danielle Keatley
| Companies | Position | End |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Investor Relations Contact | 01/08/2021 |
| STRUCTURE THERAPEUTICS INC. | Investor Relations Contact | - |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Public Communications Contact | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
- Stock Market
- Insiders
- Danielle Keatley
Choose MarketScreener 
